GRAL Grail, Inc.

$80.53 +0.03%

Updated 16 d ago

Healthcare · Services-Medical Laboratories

Grail, Inc. (GRAL) is a healthcare company in the Services-Medical Laboratories industry, with a market capitalization of $3.6 billion. Shares last traded at $80.53, 32.0% below their 52-week high. Over the past year the stock is up 147.6%. Net profit margin is -236.9%, below the peer median of -5.4%. Revenue grew 17.2% year over year.

Market Cap

$3.6B

Shares Out

44.7M

EPS (TTM)

$-22.16

P/E Ratio

—

P/S Ratio

21.77

P/B Ratio

1.41

Dividend / Share

—

Dividend Yield

—

52-Week High

$118.50

52-Week Low

$31.89

Volume

16,846

Avg Vol (3m)

30,131.73

Performance

-2.29%

+17.37%

+21.15%

+55.55%

YTD

-9.50%

+147.59%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

58.83

SMA (50)

$72.07

SMA (200)

$72.92

Price vs SMA50

+11.74%

Price vs SMA200

+10.43%

ATR (14)

$4.60

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$165M

Net Income

$-392M

Gross Margin

—

Operating Margin

-338.4%

Net Margin

-236.9%

Return on Equity

-15.4%

Return on Assets

-13.8%

Current Ratio

10.95

Debt / Equity

0.12

Revenue Growth (YoY)

+17.2%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-4.86	2026-08-06
Q1 2026	$-2.29	2026-05-07
FY 2025	$-11.11	2026-03-12
Q3 2025	$-8.73	2025-11-13
Q2 2026	$-6.28	2026-08-06
Q1 2026	$-3.10	2026-05-07

Full earnings history →

Services-Medical Laboratories peers

GRAL vs 14 industry peers (Services-Medical Laboratories), by market cap. Updated 16 d ago

P/S vs peers

21.77 / 2.75 med

+691% premium

Net margin vs peers

-236.9% / -5.4% med

below median

1–14 of 14


NTRA	Natera, Inc.	$47.2B	-245.26	17.43	-7.1%	+0.66%
LH	Labcorp	$26.9B	26.82	1.87	7.0%	-0.07%
DGX	Quest Diagnostics	$26.4B	24.88	2.29	9.2%	-0.58%
GH	Guardant Health, Inc.	$21.6B	-47.65	18.26	-38.3%	-1.23%
CAI	Caris Life Sciences, Inc.	$7.2B	68.06	7.23	10.6%	+2.14%
RDNT	Radnet, Inc.	$5.9B	-278.18	2.59	-0.9%	-1.36%
CELC	Celcuity Inc.	$4.7B	-20.82	—	—	+0.06%
BLLN	Billiontoone, Inc.	$4.6B	121.86	11.56	9.5%	+3.64%
GRAL	Grail, Inc.	$3.6B	-9.19	—	—	+0.03%
VCYT	Veracyte, Inc.	$3.6B	31.35	6.39	20.4%	-0.65%
CDNA	Caredx, Inc.	$2.6B	23.22	5.63	24.2%	+0.44%
PSNL	Personalis, Inc.	$1.8B	-16.77	—	—	+0.51%
FTRE	Fortrea Holdings Inc.	$1.8B	-20.77	0.66	-3.2%	+1.47%
LMRI	Lumexa Imaging Holdings, Inc.	$1.1B	—	—	—	-1.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.